Michael H. Buonarati

904 total citations
25 papers, 581 citations indexed

About

Michael H. Buonarati is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Michael H. Buonarati has authored 25 papers receiving a total of 581 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cancer Research, 8 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Michael H. Buonarati's work include Carcinogens and Genotoxicity Assessment (9 papers), Drug Transport and Resistance Mechanisms (8 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Michael H. Buonarati is often cited by papers focused on Carcinogens and Genotoxicity Assessment (9 papers), Drug Transport and Resistance Mechanisms (8 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Michael H. Buonarati collaborates with scholars based in United States, Canada and Australia. Michael H. Buonarati's co-authors include James S. Felton, Kenneth W. Turteltaub, Alan R. Buckpitt, Nancy H. Shen, Charles G. Plopper, Dexter Morin, Didier Morin, Ai Min Chang, A. Daniel Jones and Mark G. Knize and has published in prestigious journals such as Environmental Health Perspectives, Journal of Pharmacology and Experimental Therapeutics and Carcinogenesis.

In The Last Decade

Michael H. Buonarati

25 papers receiving 556 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael H. Buonarati United States 15 256 224 92 80 75 25 581
L T Burka United States 12 172 0.7× 213 1.0× 179 1.9× 72 0.9× 89 1.2× 29 609
P. G. Gervasi Italy 15 186 0.7× 152 0.7× 140 1.5× 57 0.7× 105 1.4× 29 506
Renee J. Duescher United States 13 252 1.0× 253 1.1× 175 1.9× 59 0.7× 123 1.6× 14 613
J. Bradley Hochalter United States 16 253 1.0× 423 1.9× 70 0.8× 44 0.6× 171 2.3× 26 768
G. David McCoy United States 16 274 1.1× 297 1.3× 153 1.7× 102 1.3× 108 1.4× 41 853
Ching Yung Wang United States 13 304 1.2× 301 1.3× 94 1.0× 55 0.7× 154 2.1× 34 704
K Wakabayashi Japan 6 276 1.1× 256 1.1× 42 0.5× 101 1.3× 81 1.1× 9 569
Donald E. Nerland United States 15 128 0.5× 188 0.8× 121 1.3× 42 0.5× 44 0.6× 30 471
B.L. Pool Germany 15 255 1.0× 199 0.9× 156 1.7× 67 0.8× 153 2.0× 49 667
Parvaneh Espandiari United States 19 171 0.7× 279 1.2× 104 1.1× 55 0.7× 302 4.0× 29 865

Countries citing papers authored by Michael H. Buonarati

Since Specialization
Citations

This map shows the geographic impact of Michael H. Buonarati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael H. Buonarati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael H. Buonarati more than expected).

Fields of papers citing papers by Michael H. Buonarati

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael H. Buonarati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael H. Buonarati. The network helps show where Michael H. Buonarati may publish in the future.

Co-authorship network of co-authors of Michael H. Buonarati

This figure shows the co-authorship network connecting the top 25 collaborators of Michael H. Buonarati. A scholar is included among the top collaborators of Michael H. Buonarati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael H. Buonarati. Michael H. Buonarati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Buonarati, Michael H., et al.. (2019). Investigations Beyond Standard Operating Procedure on Internal Standard Response. Bioanalysis. 11(18). 1669–1678. 12 indexed citations
2.
3.
4.
Langó, József, et al.. (2002). Urinary Naphthalene Mercapturates as Biomarkers of Exposure and Stereoselectivity of Naphthalene Epoxidation. Drug Metabolism and Disposition. 30(3). 247–253. 25 indexed citations
5.
Turesky, Robert J., et al.. (1995). Metabolic processing and disposition of 2-amino-3-methylimidazo[4,5-f] quinoline (IQ), 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx), and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in nonhuman primates.. PubMed. 23. 69–77. 6 indexed citations
6.
Malfatti, Michael, Michael H. Buonarati, Kenneth W. Turteltaub, Nancy H. Shen, & James S. Felton. (1994). The Role of Sulfation and/or Acetylation in the Metabolism of the Cooked-Food Mutagen 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in Salmonella typhimurium and Isolated Rat Hepatocytes. Chemical Research in Toxicology. 7(2). 139–147. 25 indexed citations
7.
Jones, A. Daniel, Carl K. Winter, Michael H. Buonarati, & H.J. Segall. (1993). Analysis of mercapturic acid conjugates of xenobiotic compounds using negative ionization and tandem mass spectrometry. Journal of Mass Spectrometry. 22(1). 68–76. 10 indexed citations
8.
Turteltaub, Kenneth W., et al.. (1993). Low-Level Biological Dosimetry of Heterocyclic Amine Carcinogens Isolated from Cooked Food. Environmental Health Perspectives. 99. 183–183. 3 indexed citations
9.
Snyderwine, Elizabeth G., Michael H. Buonarati, James S. Felton, & Kenneth W. Turteltaub. (1993). Metabolism of the food-derived mutagen/carcinogen 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine (PhIP) in nonhuman primates. Carcinogenesis. 14(12). 2517–2522. 16 indexed citations
10.
Turteltaub, Kenneth W., John S. Vogel, Christopher E. Frantz, Michael H. Buonarati, & James S. Felton. (1993). Low-level biological dosimetry of heterocyclic amine carcinogens isolated from cooked food.. Environmental Health Perspectives. 99. 183–186. 14 indexed citations
11.
Buckpitt, Alan R., et al.. (1992). Relationship of cytochrome P450 activity to Clara cell cytotoxicity. II. Comparison of stereoselectivity of naphthalene epoxidation in lung and nasal mucosa of mouse, hamster, rat and rhesus monkey.. Journal of Pharmacology and Experimental Therapeutics. 261(1). 364–372. 74 indexed citations
12.
Buonarati, Michael H., et al.. (1992). Metabolism of 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine (PHIP) in mice. Carcinogenesis. 13(4). 621–627. 26 indexed citations
13.
Felton, James S., K.W. Turteltaub, Michael H. Buonarati, et al.. (1991). Mutagens and Carcinogens in Cooked Foods: Concentration, Potency and Risk. Advances in experimental medicine and biology. 289. 133–133. 5 indexed citations
14.
Felton, James S., K.W. Turteltaub, Barton L. Gledhill, et al.. (1991). DNA dosimetry following carcinogen exposure using accelerator mass spectrometry and 32P-postlabeling.. PubMed. 372. 243–53. 3 indexed citations
15.
Buonarati, Michael H., James D. Tucker, J.L. Minkler, et al.. (1991). Metabolic activation and cytogenetic effects of 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine (PhIP) in Chinese hamster ovary cells expressing murine cytochrome P450 IA2. Mutagenesis. 6(4). 253–259. 26 indexed citations
16.
Turteltaub, Kenneth W., Mark G. Knize, Michael H. Buonarati, et al.. (1990). Metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine (PhIP) by liver microsomes and isolated rabbit cytochrome P450 isozymes. Carcinogenesis. 11(6). 941–946. 36 indexed citations
17.
Buonarati, Michael H. & James S. Felton. (1990). Activation of 2-amino-1-methyl-6-phenyimidazo[4,5-b] pyridine (PhIP) to mutagenic metabolites. Carcinogenesis. 11(7). 1133–1138. 54 indexed citations
18.
Buonarati, Michael H., A. Daniel Jones, & Alan R. Buckpitt. (1990). In vivo metabolism of isomeric naphthalene oxide glutathione conjugates.. Drug Metabolism and Disposition. 18(2). 183–189. 22 indexed citations
19.
Buonarati, Michael H., Kenneth W. Turteltaub, Nancy H. Shen, & James S. Felton. (1990). Role of sulfation and acetylation in the activation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine to intermediates which bind DNA. Mutation Research Letters. 245(3). 185–190. 94 indexed citations
20.
Buonarati, Michael H., Dexter Morin, Charles G. Plopper, & Alan R. Buckpitt. (1989). Glutathione depletion and cytotoxicity by naphthalene 1,2-oxide in isolated hepatocytes. Chemico-Biological Interactions. 71(2-3). 147–165. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by L T Burka Breakdown of academic impact, for papers by P. G. Gervasi Breakdown of academic impact, for papers by Renee J. Duescher Breakdown of academic impact, for papers by J. Bradley Hochalter Breakdown of academic impact, for papers by G. David McCoy Breakdown of academic impact, for papers by Ching Yung Wang Breakdown of academic impact, for papers by K Wakabayashi Breakdown of academic impact, for papers by Donald E. Nerland Breakdown of academic impact, for papers by B.L. Pool Breakdown of academic impact, for papers by Parvaneh Espandiari
Rankless by CCL
2026